과제정보
This research is supported by Nexmos (KHU-20182507U0054101S000100) and National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2020R1A2B5B0100276611).
참고문헌
- Radhakrishnan DM, Goyal V. Parkinson's disease: a review. Neurology India. 2018;66(Suppl):S26-S35. https://doi.org/10.4103/0028-3886.226451.
- Santos Garcia D, Labandeira Guerra C, Yanez Bana R, Cimas Hernando MI, Cabo Lopez I, Paz Gonalez JM, et al. Safinamide improves non-motor symptoms burden in parkinson's disease: an open-label prospective study. Brain Sciences. 2021;11(3):316. https://doi.org/10.3390/brainsci11030316.
- Lee JE, Choi JK, Lim HS, Kim JH, Cho JH, Kim GS, et al. The prevalence and incidence of parkinson's disease in South Korea: a 10-year nationwide population: Based Study. Journal of the Korean Neurological Association. 2017;35(4):191-198. https://doi.org/10.17340/jkna.2017.4.1
- Hallett M. Parkinson's disease tremor: pathophysiology. Parkinsonism Related Disorders. 2012;18 Suppl 1:S85-S86. https://doi.org/10.1016/s1353-8020(11)70027-x
- Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, et al. Parkinson disease. Nature Reviews Disease Primers. 2017;3:17013. https://doi.org/10.1038/nrdp.2017.13
- Mallach A, Weinert M, Arthur J, Gveric D, Tierney TS, Alavian KN. Post mortem examination of parkinson's disease brains suggests decline in mitochondrial biomass, reversed by deep brain stimulation of subthalamic nucleus. FASEB Journal. 2019;33(6):6957-6961. https://doi.org/10.1096/fj.201802628r
- Tanner CM, Langston JW. Do environmental toxins cause Parkinson's disease? A critical review. Neurology. 1990;40(10 Suppl 3):S17-S30.
- Trist BG, Hare DJ, Double KL. Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease. Aging Cell. 2019;18(6):e13031. https://doi.org/10.1111/acel.13031
- Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension. 2003;42(6):1075-1081. https://doi.org/10.1161/01.HYP.0000100443.09293.4F.
- Hwang O. Role of oxidative stress in Parkinson's disease. Experimental Neurobiology. 2013;22(1):11-17. https://doi.org/10.5607/en.2013.22.1.11
- Djuric G, Markovic V, Pekmezovic T, Tomic A, Kresojevic N, Kostic V, et al. Risk factors for levodopa-induced dyskinesia in parkinson's disease patients. Vojnosanitetski Pregled. 2017;74(10):921-926. https://doi.org/10.2298/VSP150723264D
- Lyons KE, Pahwa R. Diagnosis and initiation of treatment in parkinson's disease. The International Journal of Neuroscience. 2011;121 Suppl 2:27-36. https://doi.org/10.3109/00207454.2011.620197
- Athauda D, Foltynie T. The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in parkinson's disease: mechanisms of action. Drug Discovery Today. 2016;21(5):802-818. https://doi.org/10.1016/j.drudis.2016.01.013
- Glotfelty EJ, Olson L, Karlsson TE, Li Y, Greig NH. Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for parkinson's disease. Expert Opinion on Investigational Drugs. 2020;29(6):595-602. https://doi.org/10.1080/13543784.2020.1764534.
- Grieco M, Giorgi A, Gentile MC, d'Erme M, Morano S, Maras B, Filardi T. Glucagon-like peptide-1: a focus on neurodegenerative diseases. Frontiers in Neuroscience. 2019;13:1112. https://doi.org/10.3389/fnins.2019.01112
- Fields CR, Bengoa-Vergniory N, Wade-Martins R. Targeting alpha-synuclein as a therapy for parkinson's disease. Frontiers in Molecular Neuroscience. 2019;12:299. https://doi.org/10.3389/fnmol.2019.00299
- Jang SE, Qiu L, Chan LL, Tan EK, Zeng L. Current status of stem cell-derived therapies for parkinson's disease: from cell assessment and imaging modalities to clinical trials. Frontiers in Neuroscience. 2020;14:558532. https://doi.org/10.3389/fnins.2020.558532
- Dawson TM, Ko HS, Dawson VL. Genetic animal models of parkinson's disease. Neuron. 2010;66(5):646-661. https://doi.org/10.1016/j.neuron.2010.04.034
- Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983;219(4587):979-980. https://doi.org/1126/science.6823561 https://doi.org/10.1126/science.6823561
- Marini AM, Lipsky RH, Schwartz JP, Kopin IJ. Accumulation of 1-methyl4-phenyl-1,2,3,6-tetrahydropyridine in cultured cerebellar astrocytes. Journal of Neurochemistry. 1992;58(4):1250-1258. https://doi.org/10.1111/j.1471-4159.1992.tb11336.x
- Watanabe Y, Himeda T, Araki T. Mechanisms of MPTP toxicity and their implications for therapy of parkinson's disease. Medical Science Monitor. 2005;11(1):RA17-23.
- Andersen JK, Chinta S. Parkinson's disease and aging. In: Sierra F, Kohanski R, editors. Advances in geroscience. 1st ed. Basel: Springer; 2016. P.229-255. https://doi.org/10.1007/978-3-319-23246-1.
- Duty S, Jenner P. Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease. British Journal of Pharmacology. 2011;164(4):1357-1391. https://doi.org/10.1111/j.1476-5381.2011.01426.x
- Oudemans-van Straaten HM, Spoelstra-de Man AM, de Waard MC. Vitamin C revisited. Critical Care. 2014;18(4):460. https://doi.org/10.1186/s13054-014-0460-x
- Rani L, Sharma N, Singh S, Grewal AS. Therapeutic potential of vitamin c: an overview of various biological activities. International Journal of Pharmaceutical Quality Assurance. 2019;10(04):605-612. https://doi.org/10.25258/ijpqa.10.4.8
- Sun H, Zu Y. A highlight of recent advances in aptamer technology and its application. Molecules. 2015;20(7):11959-11980. https://doi.org/10.3390/molecules200711959
- Choi S, Han J, Kim JH, Kim AR, Kim SH, Lee W, et al. Advances in dermatology using DNA aptamer "Aptamin C" innovation: oxidative stress prevention and effect maximization of vitamin C through antioxidation. Journal of Cosmetic Dermatology. 2020;19(4):970-976. https://doi.org/10.1111/jocd.13081
- Song MK, Lee JH, Kim J, Kim JH, Hwang S, Kim YS, et al. Neuroprotective effect of NXP031 in the MPTP-induced Parkinson's disease model. Neuroscience Letters. 2021;740:135425. https://doi.org/10.1016/j.neulet.2020.135425
- Munoz-Manchado AB, Villadiego J, Romo-Madero S, Suarez-Luna N, Bermejo-Navas A, Rodriguez-Gomez JA, et al. Chronic and progressive parkinson's disease MPTP model in adult and aged mice. Journal of Neurochemistry. 2016;136(2):373-387. https://doi.org/10.1111/jnc.13409
- Bhaduri B, Abhilash PL, Alladi PA. Baseline striatal and nigral interneuronal protein levels in two distinct mice strains differ in accordance with their MPTP susceptibility. Journal of Chemical Neuroanatomy. 2018;91:46-54. https://doi.org/10.1016/j.jchemneu.2018.04.005
- Liebetanz D, Baier PC, Paulus W, Meuer K, Bahr M, Weishaupt JH. A highly sensitive automated complex running wheel test to detect latent motor deficits in the mouse MPTP model of Parkinson's disease. Experimental Neurology. 2007;205(1):207-213. https://doi.org/10.1016/j.expneurol.2007.01.030
- Smeyne M, Goloubeva O, Smeyne RJ. Strain-dependent susceptibility to MPTP and MPP(+)-induced parkinsonism is determined by glia. Glia. 2001;34(2):73-80. https://doi.org/10.1002/glia.1042
- Compton DR, Hudzik TJ. Neurochemistry of abuse liability assessment and primary behavioral correlates. In: Carrie G. Markgraf, Thomas J. Hudzik, David R. Compton, Editors. Nonclinical assessment of abuse potential for new pharmaceuticals. 1st ed. Cambridge, MA: Academic Press; 2015. p. 9-48. https://doi.org/10.1016/B978-0-12-420172-9.00002-3
- Hansen SN, Tveden-Nyborg P, Lykkesfeldt J. Does vitamin C deficiency affect cognitive development and function? Nutrients. 2014;6(9):3818-3846. https://doi.org/10.3390/nu6093818
- Bornstein SR, Yoshida-Hiroi M, Sotiriou S, Levine M, Hartwig HG, Nussbaum RL, et al. Impaired adrenal catecholamine system function in mice with deficiency of the ascorbic acid transporter (SVCT2). FASEB Journal. 2003;17(13):1928-1930. https://doi.org/10.1096/fj.02-1167fje
- Seitz G, Gebhardt S, Beck JF, Bohm W, Lode HN, Niethammer D, et al. Ascorbic acid stimulates DOPA synthesis and tyrosine hydroxylase gene expression in the human neuroblastoma cell line SK-N-SH. Neuroscience Letters. 1998;244(1):33-36. https://doi.org/10.1016/s0304-3940(98)00129-3
- Yan J, Studer L, McKay RD. Ascorbic acid increases the yield of dopaminergic neurons derived from basic fibroblast growth factor expanded mesencephalic precursors. Journal of Neurochemistry. 2001;76(1):307-311. https://doi.org/10.1046/j.1471-4159.2001.00073.x
- Hantikainen E, Trolle Lagerros Y, Ye W, Serafini M, Adami HO, Bellocco R, et al. Dietary antioxidants and the risk of parkinson disease: The Swedish National March Cohort. Neurology. 2021;96(6):e895-e903. https://doi.org/10.1212/WNL.0000000000011373
- Choi S, Hwang Y, Kim T, Kim JH. Effects of oxidative stress prevention using DNA aptamer (Aptamin C®) in keratinocyte. Highlights on Medicine and Medical Science. 2021;17:9-16. https://doi.org/10.9734/bpi/hmms/v17/2795F
- Mustapha M, Mat Taib CN. MPTP-induced mouse model of Parkinson's disease: a romising direction of therapeutic strategies. Bosnian Journal of Basic Medical Sciences. 2021;21(4):422-433. https://doi.org/10.17305/bjbms.2020.5181
- Desole MS, Miele M, Esposito G, Fresu LG, Migheli R, Zangani D, et al. Neuronal antioxidant system and MPTP-induced oxidative stress in the striatum and brain stem of the rat. Pharmacology, Biochemistry, and Behavior. 1995;51(4):581-592. https://doi.org/10.1016/0091-3057(94)00401-4
- Rice ME. Ascorbate regulation and its neuroprotective role in the brain. Trends in Neurosciencens. 2000;23(5):209-216. https://doi.org/10.1016/s0166-2236(99)01543-x
- Acuna AI, Esparza M, Kramm C, Beltran FA, Parra AV, Cepeda C, et al. A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington's disease in mice. Nature Communications. 2013;4:2917. https://doi.org/10.1038/ncomms3917.
- Wang X, Michaelis EK. Selective neuronal vulnerability to oxidative stress in the brain. Frontiers in Aging Neuroscience. 2010;2:12. https://doi.org/10.3389/fnagi.2010.00012
- Harrison FE, May JM. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radical Biology & Medicine. 2009;46(6):719-730. https://doi.org/10.1016/j.freeradbiomed.2008.12.018
- Badanjak K, Fixemer S, Smajic S, Skupin A, Grunewald A. The contribution of microglia to neuroinflammation in prkinson's disease. International Journal of Molecular Sciences. 2021;22(9):4676. https://doi.org/10.3390/ijms22094676
- Das S, Basu A. Inflammation: a new candidate in modulating adult neurogenesis. Journal of Neuroscience Research. 2008;86(6):1199-1208. http://doi:10.1002/jnr.21585